Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)
CNY 14.03
(1.45%)
CNY 14.03
(1.45%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 846.41 Million CNY | 106.11% |
| 2022 | 410.66 Million CNY | -51.03% |
| 2021 | 838.58 Million CNY | 60.73% |
| 2020 | 521.74 Million CNY | 105.55% |
| 2019 | 253.82 Million CNY | 52.99% |
| 2018 | 165.9 Million CNY | 260.26% |
| 2017 | -103.52 Million CNY | -77.99% |
| 2016 | -58.16 Million CNY | 16.38% |
| 2015 | -69.54 Million CNY | -166.96% |
| 2014 | -26.05 Million CNY | -157.66% |
| 2013 | 45.18 Million CNY | -67.41% |
| 2012 | 138.63 Million CNY | 3005.46% |
| 2011 | 4.46 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 1.05 Billion CNY | -16.27% |
| 2024 Q1 | 933.46 Million CNY | 10.28% |
| 2024 Q2 | 856.29 Million CNY | -8.27% |
| 2023 Q1 | 550.89 Million CNY | 34.15% |
| 2023 Q4 | 846.41 Million CNY | 27.0% |
| 2023 Q3 | 666.47 Million CNY | 12.21% |
| 2023 Q2 | 593.94 Million CNY | 7.81% |
| 2023 FY | 846.41 Million CNY | 106.11% |
| 2022 Q4 | 410.66 Million CNY | -56.21% |
| 2022 FY | 410.66 Million CNY | -51.03% |
| 2022 Q3 | 937.79 Million CNY | -0.96% |
| 2022 Q2 | 946.9 Million CNY | 9.33% |
| 2022 Q1 | 866.12 Million CNY | 3.28% |
| 2021 Q2 | 786.96 Million CNY | -17.89% |
| 2021 FY | 838.58 Million CNY | 60.73% |
| 2021 Q1 | 958.37 Million CNY | 83.69% |
| 2021 Q4 | 838.58 Million CNY | 0.88% |
| 2021 Q3 | 831.31 Million CNY | 5.64% |
| 2020 Q1 | 150.21 Million CNY | -40.82% |
| 2020 Q2 | 407.82 Million CNY | 171.49% |
| 2020 Q3 | 371.55 Million CNY | -8.89% |
| 2020 FY | 521.74 Million CNY | 105.55% |
| 2020 Q4 | 521.74 Million CNY | 40.42% |
| 2019 Q3 | 51.56 Million CNY | 181.38% |
| 2019 Q1 | 181.41 Million CNY | 9.35% |
| 2019 FY | 253.82 Million CNY | 52.99% |
| 2019 Q4 | 253.82 Million CNY | 392.25% |
| 2019 Q2 | 18.32 Million CNY | -89.9% |
| 2018 Q2 | 216.67 Million CNY | 1606.86% |
| 2018 FY | 165.9 Million CNY | 260.26% |
| 2018 Q4 | 165.9 Million CNY | -41.05% |
| 2018 Q3 | 281.41 Million CNY | 29.88% |
| 2018 Q1 | -14.37 Million CNY | 86.11% |
| 2017 Q3 | -164.8 Million CNY | 61.49% |
| 2017 Q2 | -427.94 Million CNY | 8.7% |
| 2017 Q1 | -468.73 Million CNY | -705.92% |
| 2017 FY | -103.52 Million CNY | -77.99% |
| 2017 Q4 | -103.52 Million CNY | 37.19% |
| 2016 Q4 | -58.16 Million CNY | 0.0% |
| 2016 Q1 | 99.54 Million CNY | 0.0% |
| 2016 FY | -58.16 Million CNY | 16.38% |
| 2015 FY | -69.54 Million CNY | -166.96% |
| 2014 Q4 | -26.05 Million CNY | 0.0% |
| 2014 Q1 | 50.28 Million CNY | 0.0% |
| 2014 FY | -26.05 Million CNY | -157.66% |
| 2014 Q2 | 50.28 Million CNY | 0.0% |
| 2013 FY | 45.18 Million CNY | -67.41% |
| 2012 FY | 138.63 Million CNY | 3005.46% |
| 2011 FY | 4.46 Million CNY | 0.0% |